首页> 外文期刊>Nucleic acids research >Methylation Inhibitors Can Increase the Rate of Cytosine Deamination by (Cytosine-5)-DNA Methyltransferase
【24h】

Methylation Inhibitors Can Increase the Rate of Cytosine Deamination by (Cytosine-5)-DNA Methyltransferase

机译:甲基化抑制剂可提高(Cytosine-5)-DNA甲基转移酶的胞嘧啶脱氨速率

获取原文
           

摘要

The target cytosines of (cytosine-5)-DNA methyltransferases in prokaryotic and eukaryotic DNA show increased rates of C→T transition mutations compared to non-target cytosines. These mutations are induced either by the spontaneous deamination of 5-mC→T generating inefficiently repaired G:T rather than G:U mismatches, or by the enzyme-induced C→U deamination which occurs under conditions of reduced levels of S-adenosylmethionine (AdoMet) and S-adenosyl-homocysteine (AdoHcy). We tested whether various inhibitors of (cytosine-5)-DNA methyltransferases analogous to AdoMet and AdoHcy would affect the rate of enzyme-induced deamination of the target cytosine by M.HpaII and M.SssI. Interestingly, we found two compounds, sinefungin and 5′-amino-5′-deoxyadenosine, that increased the rate of deamination 103-fold in the presence and 104-fold in the absence of AdoMet and AdoHcy. We have therefore identified the first mutagenic compounds specific for the target sites of (cytosine-5)-DNA methyltransferases. A number of analogs of AdoMet and AdoHcy have been considered as possible antiviral, anticancer, antifungal and anti-parasitic agents. Our findings show that chemotherapeutic agents with affinities to the cofactor binding pocket of (cytosine-5)-DNA methyltransferase should be tested for their potential mutagenic effects.
机译:与非靶标胞嘧啶相比,原核和真核DNA中(cytosine-5)-DNA甲基转移酶的靶标胞嘧啶显示出C→T过渡突变的发生率增加。这些突变是由5-mC→T的自发脱氨基反应产生的,而G:T的修复效率低下,而不是由G:U错配引起的,或者是由酶诱导的C→U脱氨作用引起的,这种情况是在S-腺苷甲硫氨酸水平降低的条件下发生的( AdoMet)和S-腺苷-高半胱氨酸(AdoHcy)。我们测试了各种类似于AdoMet和AdoHcy的(cytosine-5)-DNA甲基转移酶抑制剂是否会影响M.HpaII和M.SssI对酶诱导的目标胞嘧啶脱氨的速率。有趣的是,我们发现了西非芬净和5'-氨基-5'-脱氧腺苷这两种化合物,在存在和10 4 -的情况下,其脱氨速率提高了10 3 -倍。在没有AdoMet和AdoHcy的情况下折叠。因此,我们确定了第一种特异性针对(cytosine-5)-DNA甲基转移酶靶位点的诱变化合物。人们认为AdoMet和AdoHcy的许多类似物可能是抗病毒药,抗癌药,抗真菌药和抗寄生虫药。我们的研究结果表明,应测试与(cytosine-5)-DNA甲基转移酶的辅因子结合袋具有亲和力的化学治疗剂的潜在诱变作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号